BMY-28100 in internal infections

Hiroshi Kawabe; Yasuo Matsuoka; Shoichiro Irimajiri

doi:10.11250/chemotherapy1953.37.Supplement3_300

BMY-28100 in internal infections

Hiroshi Kawabe, Yasuo Matsuoka, Shoichiro Irimajiri

Health Center

Research output: Contribution to journal › Article › peer-review

Abstract

A new antibiotic, BMY-28100, was administered for 4-17 days at a daily dose of 750 or 1500mg to 22 patients (pneumonia 4 cases, acute bronchitis 4, acute tonsillitis 3, acute pharyngitis 4, acute pyelonephritis 5, and acute cystitis 2). The results were effective in 16 cases, and the overall efficacy rate was 72.7%. A side effect was observed in 1 patient (eruption), and abnormal laboratory findings were observed in 4 (3 cases of GPT and 1 of GOT, GPT elevation).

Original language	English
Pages (from-to)	300-304
Number of pages	5
Journal	Chemotherapy
Volume	37
DOIs	https://doi.org/10.11250/chemotherapy1953.37.Supplement3_300
Publication status	Published - 1989 Jan 1

ASJC Scopus subject areas

Pharmacology (medical)
Infectious Diseases
Pharmacology
Drug Discovery
Oncology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.11250/chemotherapy1953.37.Supplement3_300

Cite this

@article{466c1dbd6316445ab436c4fc4382a7ce,

title = "BMY-28100 in internal infections",

abstract = "A new antibiotic, BMY-28100, was administered for 4-17 days at a daily dose of 750 or 1500mg to 22 patients (pneumonia 4 cases, acute bronchitis 4, acute tonsillitis 3, acute pharyngitis 4, acute pyelonephritis 5, and acute cystitis 2). The results were effective in 16 cases, and the overall efficacy rate was 72.7%. A side effect was observed in 1 patient (eruption), and abnormal laboratory findings were observed in 4 (3 cases of GPT and 1 of GOT, GPT elevation).",

author = "Hiroshi Kawabe and Yasuo Matsuoka and Shoichiro Irimajiri",

year = "1989",

month = jan,

day = "1",

doi = "10.11250/chemotherapy1953.37.Supplement3_300",

language = "English",

volume = "37",

pages = "300--304",

journal = "CHEMOTHERAPY",

issn = "0009-3165",

}

TY - JOUR

T1 - BMY-28100 in internal infections

AU - Kawabe, Hiroshi

AU - Matsuoka, Yasuo

AU - Irimajiri, Shoichiro

PY - 1989/1/1

Y1 - 1989/1/1

N2 - A new antibiotic, BMY-28100, was administered for 4-17 days at a daily dose of 750 or 1500mg to 22 patients (pneumonia 4 cases, acute bronchitis 4, acute tonsillitis 3, acute pharyngitis 4, acute pyelonephritis 5, and acute cystitis 2). The results were effective in 16 cases, and the overall efficacy rate was 72.7%. A side effect was observed in 1 patient (eruption), and abnormal laboratory findings were observed in 4 (3 cases of GPT and 1 of GOT, GPT elevation).

AB - A new antibiotic, BMY-28100, was administered for 4-17 days at a daily dose of 750 or 1500mg to 22 patients (pneumonia 4 cases, acute bronchitis 4, acute tonsillitis 3, acute pharyngitis 4, acute pyelonephritis 5, and acute cystitis 2). The results were effective in 16 cases, and the overall efficacy rate was 72.7%. A side effect was observed in 1 patient (eruption), and abnormal laboratory findings were observed in 4 (3 cases of GPT and 1 of GOT, GPT elevation).

UR - http://www.scopus.com/inward/record.url?scp=0024930850&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024930850&partnerID=8YFLogxK

U2 - 10.11250/chemotherapy1953.37.Supplement3_300

DO - 10.11250/chemotherapy1953.37.Supplement3_300

M3 - Article

AN - SCOPUS:0024930850

SN - 0009-3165

VL - 37

SP - 300

EP - 304

JO - CHEMOTHERAPY

JF - CHEMOTHERAPY

ER -

BMY-28100 in internal infections

Abstract

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this